title: [Distribution of therapeutic procedures and choice of drug therapies in patients with angiographically confirmed coronary artery disease].
abstract: OBJECTIVE
  The aims of our study were to assess the distribution of interventional and other therapeutic procedures performed on subjects who had proven CAD by angiography in our clinic; to determine the groups of therapeutic agents prescribed at the time of discharge; and to compare these with the results of EUROASPIRE II, which examined the prophylactic drug therapy upon discharge of CAD patients in 15 European countries.
  
  
  METHODS
  Our patients comprises of 617 subjects (516 male, 101 female; mean age 57.2 +/- 10.8 years) who underwent coronary angiography for the first time in our clinic and who were found to have a 50% lesion in at least one of the coronary arteries. In all patients distribution of risk factors on admission, distribution of therapeutic procedures and the use of drug therapies at the hospital discharge were recorded.
  
  
  RESULTS
  We found that, 68% of our cases were considered to be eligible for a percutaneous or surgical intervention, while 27% were assessed not as requiring such an intervention and consequently were discharged being prescribed appropriate medications. For the remaining 5% of the subjects, tests for detection of viable myocardium were advised, before selecting the proper type of management. At discharge, prescription rates for antiplatelets, beta-blockers, nitrates, statins, angiotensin-converting enzyme inhibitors (ACE-I), calcium channel blockers and anticoagulants were detected to be %99, 86%, 86%, 63%, 40%, 16%, and 2% respectively.
  
  
  CONCLUSIONS
  Compared with the results of EUROASPIRE II study, these data show that, antiplatelet, beta-blocker, ACE-I and lipid-lowering treatments our subjects received upon discharge were higher, whereas anticoagulant treatment was lower than the averages of the fifteen European countries consisting the EUROASPIRE II study.
authors.affiliation: Koşuyolu Kalp Eğitim ve Araştirma Hastanesi Kardiyoloji Kliniği, Istanbul. sonmezk@hotmail.com
authors.forename: Kenan
authors.initials: K
authors.lastname: Sönmez
authors.forename: Ahmet
authors.initials: A
authors.lastname: Akçay
authors.forename: Mustafa
authors.initials: M
authors.lastname: Akçakoyun
authors.forename: Durmuş
authors.initials: D
authors.lastname: Demir
authors.forename: Orhan Hakan
authors.initials: OH
authors.lastname: Elönü
authors.forename: Ozgür
authors.initials: O
authors.lastname: Onat
authors.forename: Nilüfer Ekşi
authors.initials: NE
authors.lastname: Duran
authors.forename: Murat
authors.initials: M
authors.lastname: Gençbay
authors.forename: Muzaffer
authors.initials: M
authors.lastname: Değertekin
authors.forename: Fikret
authors.initials: F
authors.lastname: Turan
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000706:statistics & numerical data; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000706:statistics & numerical data; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D005060:Europe; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D010351:Patient Discharge; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D012307:Risk Factors; D014421:Turkey